Other general symptoms and signs

R18_OTHER_GENERAL_SYMPTOMS_SIGNS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R68 Cause of death: ICD-10 — R68 2 out of 7 registries used, show all original rules.	2127
4. Check minimum number of events None	2127
5. Include endpoints None	2127
6. Filter based on genotype QC (FinnGen only)	2127

Control definitions (FinnGen only)

Control exclude: R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R[5-6]
Name in latin: Alia symptomata et signa generalia

NAME	R18_OTHER_GENERAL_SYMPTOMS_SIGNS
CONTROL_EXCLUDE	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R68
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R68
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other general symptoms and signs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2127	1405	722
Unadjusted period prevalence (%)	0.42	0.48	0.32
Median age at first event (years)	49.76	47.11	54.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1867: Matched controls
18517

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

423.8

323.0

587

R68.8

ICD-10 Finland

Other specified general symptoms and signs

441.2

323.0

643

R68.2

ICD-10 Finland

Dry mouth, unspecified

200.0

323.0

359

R68.1

ICD-10 Finland

Nonspecific symptoms peculiar to infancy

750.1

209.2

203

R51.80

ICD-10 Finland

Headache

9.7

168.2

367

454

R53

ICD-10 Finland

Malaise and fatigue

5.4

149.6

520

1230

R50.9

ICD-10 Finland

Fever, unspecified

8.6

139.0

324

440

R55

ICD-10 Finland

Syncope and collapse

20.1

113.4

174

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.5

106.9

631

2349

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

104.2

849

3978

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

94.4

808

3842

R56.8

ICD-10 Finland

Other and unspecified convulsions

129.5

92.6

R68.81

ICD-10 Finland

A constant or recurrent sensitivity to experience symptoms and signs in relation to common factors in the environment, not elsewhere classified.

245.2

92.1

R06.0

ICD-10 Finland

Dyspnoea

3.3

88.5

537

1993

AA1AD

NOMESCO Finland

CT of head and brain

3.6

82.0

438

1462

M79.6

ICD-10 Finland

Pain in limb

2.7

79.3

725

3488

N06AX21

ATC

duloxetine; oral

4.7

78.7

295

711

A02BC02

ATC

pantoprazole; systemic

2.5

76.1

1141

7171

N03AX16

ATC

pregabalin; oral

3.2

74.3

477

1810

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.6

71.7

377

1228

UJF32

NOMESCO Finland

Coloscopy

3.0

69.6

502

2050

SPAT1301

SPAT

No procedures

2.5

65.0

690

3517

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

65.0

330

1038

H02AB06

ATC

prednisolone; systemic

2.4

64.9

863

4940

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.1

64.1

410

1531

N03AX12

ATC

gabapentin; oral

3.6

64.0

323

1010

N06AX11

ATC

mirtazapine; oral

2.5

61.9

607

2947

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.2

60.7

365

1301

N06AX16

ATC

venlafaxine; oral

3.4

60.5

337

1135

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

13.9

60.4

106

R03AC02

ATC

salbutamol; inhalant

2.2

59.0

1054

6828

A02BC01

ATC

omeprazole; systemic

2.6

58.5

525

2410

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

58.3

317

1045

A02BC05

ATC

esomeprazole; systemic

2.3

57.2

733

4044

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

57.1

548

2606

N05BA04

ATC

oxazepam; oral

2.6

56.5

495

2233

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

7.0

56.3

145

219

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.3

56.0

671

3576

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

55.8

467

2051

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

55.6

824

4850

M54.5

ICD-10 Finland

Low back pain

2.4

55.6

624

3212

R42

ICD-10 Finland

Dizziness and giddiness

2.9

55.5

405

1634

N02AX02

ATC

tramadol; systemic, rectal

2.3

55.4

711

3909

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.9

53.4

243

690

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.4

53.1

205

500

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

50.1

569

2918

N05AH04

ATC

quetiapine; oral

2.8

48.8

360

1452

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

4.2

48.4

200

519

G44.2

ICD-10 Finland

Tension-type headache

3.1

47.6

288

1017

M25.5

ICD-10 Finland

Pain in joint

2.3

47.5

562

2922

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.8

45.9

212

607

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.1

45.8

289

1047

R68.0

ICD-10 Finland

Hypothermia, not associated with low environmental temperature

444.3

44.3

K30

ICD-10 Finland

Functional dyspepsia

3.4

44.2

230

725

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

43.4

368

1598

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

43.3

380

1683

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

43.2

674

3933

R52.9

ICD-10 Finland

Pain, unspecified

4.2

42.9

173

438

SPAT1263

SPAT

Sampling

2.0

42.8

818

5181

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

42.6

460

2269

N02BE01

ATC

paracetamol; systemic, rectal

2.1

42.1

1472

11756

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

41.9

350

1506

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.9

41.2

184

511

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

40.3

924

6224

N06AB04

ATC

citalopram; systemic

2.4

40.0

406

1935

N03AE01

ATC

clonazepam; systemic

5.1

39.5

131

271

N06AB06

ATC

sertraline; oral

3.0

39.5

253

923

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.4

39.5

208

660

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.7

38.9

183

530

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

38.9

407

1965

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.0

38.8

243

871

G47.3

ICD-10 Finland

Sleep apnoea

2.5

38.8

351

1571

R60.0

ICD-10 Finland

Localized oedema

3.9

38.6

167

450

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

38.0

416

2050

SPAT1240

SPAT

Therapeutic discussion

2.8

37.9

273

1072

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.1

37.5

231

817

G93.3

ICD-10 Finland

Postviral fatigue syndrome

55.8

37.3

WX110

NOMESCO Finland

Local anesthesy

1.9

37.3

1283

9878

J01MA12

ATC

levofloxacin; systemic

2.6

37.1

311

1334

N06AA09

ATC

amitriptyline; systemic

3.5

37.1

188

578

R52.2

ICD-10 Finland

Other chronic pain

8.3

36.7

103

C07AA05

ATC

propranolol; systemic

2.3

36.2

384

1861

M79.7

ICD-10 Finland

Fibromyalgia

6.5

35.7

154

A02BC03

ATC

lansoprazole; oral

2.1

35.4

467

2496

J01DB01

ATC

cefalexin; oral

2.0

35.3

1457

11851

SPAT1312

SPAT

General health counselling

1.9

35.1

681

4247

SPAT1262

SPAT

Handing over of treatment supplies

2.5

35.0

318

1419

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.4

34.8

178

551

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

34.5

546

3141

J01FF01

ATC

clindamycin; systemic

2.1

34.5

461

2476

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

34.3

614

3709

R07.3

ICD-10 Finland

Other chest pain

3.4

34.0

179

566

C07AB07

ATC

bisoprolol; oral

1.9

33.8

660

4111

M54.4

ICD-10 Finland

Lumbago with sciatica

2.5

33.7

292

1268

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

33.5

1317

10395

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

13.5

33.1

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.9

33.1

213

776

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

32.7

742

4860

N06AB10

ATC

escitalopram; oral

2.2

32.7

396

2031

SPAT1276

SPAT

Outlining of treatment with patient or their family members

7.9

32.6

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

32.6

158

468

UKC02

NOMESCO Finland

Cystoscopy

2.7

32.6

251

1018

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

32.4

218

816

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.6

32.4

254

1044

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.9

32.2

139

373

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

32.2

425

2262

A07AA02

ATC

nystatin; oral

4.0

32.0

135

355

C03CA01

ATC

furosemide; systemic

2.2

31.9

366

1828

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.8

31.9

141

387

XF404

NOMESCO Finland

Ambulatory ECG

3.2

31.8

179

593

L03

ICPC

Low back symptom/complaint

2.1

31.8

440

2384

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.9

31.5

212

793

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

31.5

655

4145

H04.10

ICD-10 Finland

Dry eye syndrome

2.9

31.0

201

735

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

30.9

167

538

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

30.9

247

1022

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

30.8

225

883

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.3

30.8

118

284

R11

ICD-10 Finland

Nausea and vomiting

3.2

30.7

169

551

M79.1

ICD-10 Finland

Myalgia

2.6

30.7

255

1078

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

5.3

30.7

186

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

30.7

342

1682

N05CF01

ATC

zopiclone; oral

2.0

30.5

491

2820

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.2

30.3

169

555

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.0

30.2

184

645

K59.09

ICD-10 Finland

Constipation, unspecified

4.0

29.9

125

326

M01AE02

ATC

naproxen; oral, rectal

1.8

29.9

1040

7734

SPAT1153

SPAT

Removal of sutures

1.9

29.8

511

3003

TAB00

NOMESCO Finland

Lumbar puncture

4.9

29.7

101

215

N03AX09

ATC

lamotrigine; oral

4.1

29.7

119

299

R05

ICD-10 Finland

Cough

2.1

29.3

367

1899

F32.1

ICD-10 Finland

Moderate depressive episode

3.4

29.3

149

458

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

29.3

196

730

R20.2

ICD-10 Finland

Paraesthesia of skin

3.5

29.3

143

426

R13

ICD-10 Finland

Dysphagia

3.8

29.1

129

354

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.0

29.0

182

651

Z71.8

ICD-10 Finland

Other specified counselling

2.0

28.6

454

2585

R51

ICD-10 Finland

Headache

4.1

28.6

116

295

XX3DW

NOMESCO Finland

Time consuming IT work

2.9

28.4

190

706

R03DC03

ATC

montelukast; oral

2.2

28.2

325

1615

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.7

28.2

211

841

XQ800

NOMESCO Finland

Prick test

2.7

28.2

201

779

JN3AD

NOMESCO Finland

Abdominal CT examination

3.5

28.1

140

423

WX723

NOMESCO Finland

CPAP therapy

5.1

27.8

182

N03AG01

ATC

valproic acid; systemic, rectal

3.8

27.8

123

338

XKD00

NOMESCO Finland

Uroflowmetry

2.6

27.7

218

894

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.7

27.6

125

350

N05BA12

ATC

alprazolam; oral

2.8

27.4

189

716

N02AA05

ATC

oxycodone; systemic

2.7

27.3

196

761

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.9

27.2

461

2681

R06AE07

ATC

cetirizine; oral

1.7

27.2

781

5419

S06.0

ICD-10 Finland

Concussion

2.7

27.2

198

776

WX402

NOMESCO Finland

General anaesthesia

2.1

27.1

334

1709

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

27.1

712

4804

L28

ICPC

Limited function/disability (L)

2.5

27.0

239

1044

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

26.9

389

2130

J02AC01

ATC

fluconazole; systemic

1.8

26.6

705

4763

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

34.3

26.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

26.3

733

5024

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.3

26.1

160

R01AD12

ATC

fluticasone furoate; nasal

1.8

26.1

578

3682

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

26.1

853

6127

T78.4

ICD-10 Finland

Allergy, unspecified

3.7

25.9

119

337

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.9

25.8

167

607

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

25.8

161

570

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.6

25.8

121

349

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

25.7

175

658

SBA10

NOMESCO Finland

Measurement of excretion of saliva

10.2

25.6

A06AD11

ATC

lactulose; oral

2.5

25.6

211

886

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

25.5

456

2699

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.6

25.5

207

863

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

25.4

951

7080

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

25.4

314

1606

SPAT1254

SPAT

Administration of medicine

2.2

25.3

293

1454

R51.81

ICD-10 Finland

Facial pain NOS

11.6

25.3

SPAT1081

SPAT

Cardiorespiratory global assessment

3.5

25.2

121

355

N05BA01

ATC

diazepam; systemic, rectal

2.5

25.2

208

874

J01AA02

ATC

doxycycline; systemic

1.7

25.2

1252

10091

SPAT1255

SPAT

Intravenous administration of medicine

3.5

25.1

123

367

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

25.1

339

1797

P01AB01

ATC

metronidazole; oral, rectal

1.7

25.0

649

4338

J01FA09

ATC

clarithromycin; systemic

1.8

24.9

561

3582

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

24.8

940

7000

TEA00

NOMESCO Finland

Biopsy of lip

14.2

24.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

24.7

136

443

M01AH05

ATC

etoricoxib; oral

1.7

24.6

922

6845

D82

ICPC

Teeth/gum disease

1.7

24.5

661

4462

H03AA01

ATC

levothyroxine sodium; systemic

2.0

24.5

392

2219

R52.0

ICD-10 Finland

Acute pain

6.6

24.3

R63.4

ICD-10 Finland

Abnormal weight loss

7.2

24.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

24.2

177

695

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.9

24.1

152

543

E0000UV

ATC

1.7

24.1

721

5013

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

23.9

961

7246

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.5

23.5

112

327

A03FA02

ATC

cisapride; oral, rectal

3.0

23.5

142

494

R00.2

ICD-10 Finland

Palpitations

3.0

23.5

144

505

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.4

23.4

221

994

G43.9

ICD-10 Finland

Migraine, unspecified

3.2

23.4

126

404

N30.0

ICD-10 Finland

Acute cystitis

2.2

23.4

254

1223

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.5

23.3

199

849

A02BA02

ATC

ranitidine; systemic

2.1

23.2

297

1539

M54.2

ICD-10 Finland

Cervicalgia

3.0

23.2

138

475

SPAT1284

SPAT

Extensive health certificate

4.5

23.2

192

M54

ICD-10 Finland

Dorsalgia

2.4

23.1

212

942

J01MA02

ATC

ciprofloxacin; systemic

1.7

22.9

573

3762

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

22.7

320

1719

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

22.6

171

684

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.9

22.6

250

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.3

22.5

118

371

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

12.6

22.5

P01

ICPC

Feeling anxious/nervous/tense

2.2

22.3

243

1171

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

22.3

162

631

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

22.3

313

1682

K59.0

ICD-10 Finland

Constipation

3.5

22.2

109

326

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.7

22.0

154

588

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.7

22.0

271

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.7

22.0

115

N30.9

ICD-10 Finland

Cystitis, unspecified

3.3

21.9

115

362

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.7

21.8

278

SPAT1283

SPAT

Restricted health certificate

1.8

21.8

407

2427

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.9

21.7

244

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

21.6

381

2226

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

5.5

21.5

118

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

21.5

194

854

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

21.4

278

1446

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

21.3

253

1266

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.9

21.3

149

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.4

21.3

194

856

R33

ICD-10 Finland

Retention of urine

3.3

21.2

109

338

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.5

21.1

100

291

R02

ICPC

Shortness of breath/dyspnoea

2.3

21.1

206

942

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

21.0

168

693

L01

ICPC

Neck symptom/complaint

2.2

21.0

244

1208

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

20.9

443

2748

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.3

20.9

184

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.0

20.8

223

C07AB02

ATC

metoprolol; systemic

2.0

20.8

281

1484

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.2

20.8

113

366

M03BX02

ATC

tizanidine; oral

1.6

20.7

975

7543

SPAT1377

SPAT

Polysomnography

4.2

20.7

200

K03.88

ICD-10 Finland

Other specified diseases of hard tissues of teeth

5.7

20.6

108

A01

ICPC

Pain general/multiple sites

2.8

20.6

136

499

R03AK08

ATC

formoterol and beclometasone; inhalant

4.1

20.6

206

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

20.5

241

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

20.5

377

2229

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.0

20.4

124

433

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

20.4

158

640

WX002

NOMESCO Finland

Sedation and analgesia

2.0

20.3

300

1638

N06AX26

ATC

vortioxetine; oral

3.1

20.3

117

395

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.8

20.2

136

507

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

20.2

271

1424

R60.9

ICD-10 Finland

Oedema, unspecified

4.7

20.2

149

Z01.2

ICD-10 Finland

Dental examination

1.6

20.2

782

5748

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

20.1

108

346

WX780

NOMESCO Finland

Remote monitoring CPAP

3.8

20.1

240

ELA30

NOMESCO Finland

Biopsy of salivary gland

32.7

20.1

XF402

NOMESCO Finland

ECG with work load test

2.5

20.1

164

681

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

20.0

129

467

J01EA01

ATC

trimethoprim; systemic

1.8

19.9

425

2638

D07AC01

ATC

betamethasone; topical

1.7

19.8

521

3444

L29

ICPC

Musculoskeletal sympt/complt other

2.6

19.7

146

575

R03BA05

ATC

fluticasone; inhalant

1.9

19.5

346

2018

SPAT1058

SPAT

PEF monitoring instruction

2.6

19.4

154

630

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.7

19.4

238

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

19.3

118

414

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.4

19.3

168

724

J31.0

ICD-10 Finland

Chronic rhinitis

2.5

19.2

153

627

K11.70

ICD-10 Finland

Hypoptyalism

15.6

19.2

B01AB05

ATC

enoxaparin; parenteral

1.8

19.2

404

2494

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.6

19.2

146

584

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.5

19.2

153

SPAT1139

SPAT

Nutrition survey

3.9

19.1

206

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

19.0

163

696

N03AF02

ATC

oxcarbazepine; oral

5.4

19.0

107

SPAT1260

SPAT

Consultation of another employee

1.9

18.9

299

1672

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.3

18.9

312

N06AX12

ATC

bupropion; oral

2.8

18.9

128

480

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

18.8

196

922

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.9

18.8

209

H02AB09

ATC

hydrocortisone; systemic

4.5

18.7

152

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.1

18.7

185

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

18.7

151

626

C01CA24

ATC

epinephrine; parenteral

2.6

18.7

143

574

N06AB03

ATC

fluoxetine; oral

2.1

18.6

223

1116

SPAT1234

SPAT

Support of social functional capacity

3.6

18.6

241

R35

ICD-10 Finland

Polyuria

3.2

18.6

100

322

P76

ICPC

Depressive disorder

2.7

18.6

133

515

A04

ICPC

Weakness/tiredness general

2.1

18.5

233

1192

K59.1

ICD-10 Finland

Functional diarrhoea

3.3

18.5

290

L08

ICPC

Shoulder symptom/complaint

1.9

18.3

289

1614

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

18.3

323

1876

R01AD09

ATC

mometasone; nasal

1.6

18.3

764

5678

N06AB05

ATC

paroxetine; oral

2.8

18.3

120

441

R01AD08

ATC

fluticasone; nasal

1.7

18.3

472

3090

H53.1

ICD-10 Finland

Subjective visual disturbances

2.9

18.2

114

406

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

18.1

213

1057

J20

ICD-10 Finland

Acute bronchitis

2.3

18.0

173

784

UDC00

NOMESCO Finland

Ear microscopy

2.6

17.8

139

566

K02.1

ICD-10 Finland

Caries of dentine

1.5

17.8

1002

7968

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.4

17.8

151

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.8

17.8

204

M54.6

ICD-10 Finland

Pain in thoracic spine

2.7

17.7

125

480

K02

ICD-10 Finland

Dental caries

2.5

17.7

143

591

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.0

17.6

181

H02AB04

ATC

methylprednisolone; systemic

2.1

17.6

224

1148

J01DA01

ATC

[U] cefalexin; systemic

1.5

17.5

1001

7974

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.1

17.4

173

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

17.4

1203

9998

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

17.4

235

1237

X58

ICD-10 Finland

Exposure to other specified factors

2.0

17.2

230

1204

R03BA08

ATC

ciclesonide; inhalant

2.5

17.2

146

619

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.6

17.2

128

507

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

17.1

366

2259

S18

ICPC

Laceration/cut

1.6

17.1

630

4518

N05CD07

ATC

temazepam; oral

2.3

17.1

165

748

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

17.1

219

1127

A01AB09

ATC

miconazole; local oral

2.3

17.1

162

727

M54.1

ICD-10 Finland

Radiculopathy

3.9

17.1

181

J45

ICD-10 Finland

Asthma

2.2

17.1

186

893

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

4.3

17.0

153

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

17.0

322

1913

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.5

17.0

135

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.7

17.0

119

453

F45.0

ICD-10 Finland

Somatization disorder

21.9

16.8

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

16.8

224

1171

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.9

16.7

180

SPAT1238

SPAT

Brief therapy

5.1

16.6

103

P01BA02

ATC

hydroxychloroquine; oral

2.4

16.6

143

614

R03BA01

ATC

beclometasone; inhalant

2.0

16.6

227

1201

WX320

NOMESCO Finland

Spinalanesthesy

1.8

16.5

340

2072

W19

ICD-10 Finland

Unspecified fall

2.3

16.5

156

702

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.7

16.4

198

SPAT1243

SPAT

Psychiatric/psychological examination

3.4

16.4

245

R30.0

ICD-10 Finland

Dysuria

3.4

16.4

240

R07.0

ICD-10 Finland

Pain in throat

2.6

16.3

123

490

R4110

NOMESCO Finland

Physiotherapy

1.7

16.3

395

2527

G43.3

ICD-10 Finland

Complicated migraine

7.0

16.3

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

16.3

112

423

SPAT1104

SPAT

Monitoring of emergency patient

2.7

16.3

116

448

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

16.3

206

1053

R31

ICD-10 Finland

Unspecified haematuria

2.5

16.2

128

523

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

16.2

220

1160

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.9

16.2

102

364

XA800

NOMESCO Finland

Neuropsychological investigation

3.3

16.1

259

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.7

16.1

201

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

16.1

171

812

D07AD01

ATC

clobetasol; topical

1.9

16.1

240

1307

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

7.6

16.0

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

16.0

174

833

J01FA10

ATC

azithromycin; systemic

1.5

15.9

1046

8510

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.2

15.9

267

N05AA02

ATC

levomepromazine; systemic

3.6

15.8

199

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

15.7

192

968

M01AB05

ATC

diclofenac; systemic, rectal

1.5

15.7

1007

8137

SPAT1310

SPAT

Counselling related to known health issue

1.6

15.7

533

3728

SGA01

NOMESCO Finland

Tooth opening as first aid

1.9

15.7

269

1544

J01FA06

ATC

roxithromycin; oral

1.6

15.6

609

4403

A41.9

ICD-10 Finland

Sepsis, unspecified

4.3

15.6

138

N06AX03

ATC

mianserin; oral

3.2

15.5

261

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

15.4

233

1276

N03AF01

ATC

carbamazepine; oral, rectal

3.4

15.4

230

R03BB04

ATC

tiotropium bromide; inhalant

2.4

15.4

138

603

F60.5

ICD-10 Finland

Anankastic personality disorder

6.4

15.4

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

15.4

100

366

R62.0

ICD-10 Finland

Delayed milestone

12.3

15.3

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.4

15.3

216

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

15.2

607

4410

XKC03

NOMESCO Finland

Water cystometry

4.1

15.2

146

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

15.2

120

492

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

15.1

451

3047

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

17.7

15.1

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

15.1

305

1843

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

20.1

15.0

N05CF02

ATC

zolpidem; oral

1.8

15.0

265

1535

ZXA10

NOMESCO Finland

Bilateral

1.8

14.9

288

1714

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.2

14.9

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

2.5

14.9

121

504

A02BC04

ATC

rabeprazole; oral

2.3

14.9

137

607

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

14.9

134

586

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

14.8

279

N05AX08

ATC

risperidone; systemic

2.4

14.8

127

544

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

14.8

357

2274

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

12.4

14.8

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.0

14.8

150

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

14.8

949

7631

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

14.7

266

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

14.6

357

2281

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

10.4

14.6

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

14.6

659

4911

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

14.6

138

619

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

14.6

699

5278

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

14.6

217

1182

-1

SPAT

2.7

14.6

373

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

14.5

525

3714

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

6.3

14.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

14.4

155

740

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

14.4

111

447

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

14.4

144

662

N05AH03

ATC

olanzapine; systemic

2.6

14.4

105

412

SPAT1050

SPAT

Extensive neurological examination

4.6

14.4

107

G50.1

ICD-10 Finland

Atypical facial pain

6.2

14.3

R29

ICPC

Respiratory symptom/complaint other

2.5

14.2

116

483

K07.60

ICD-10 Finland

Snapping jaw

2.7

14.2

376

SPAT1211

SPAT

Application of soft bandage

2.1

14.2

168

834

M13.9

ICD-10 Finland

Arthritis, unspecified

2.4

14.2

119

503

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

14.1

415

2789

N06BA04

ATC

methylphenidate; oral

3.3

14.0

220

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.5

14.0

109

443

R06AX27

ATC

desloratadine; oral

1.6

14.0

509

3601

R07.2

ICD-10 Finland

Precordial pain

5.6

14.0

N01

ICPC

Headache

1.9

13.9

232

1314

N17

ICPC

Vertigo/dizziness

2.1

13.8

164

817

B01AB10

ATC

tinzaparin; parenteral

2.6

13.8

101

396

N03AX11

ATC

topiramate; oral

4.5

13.8

107

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.4

13.8

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.7

13.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

13.8

379

R61.0

ICD-10 Finland

Localized hyperhidrosis

53.3

13.8

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

13.7

147

700

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

13.7

235

1344

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

13.7

257

1515

N05AF03

ATC

chlorprothixene; systemic

4.1

13.7

127

M03BX01

ATC

baclofen; systemic

6.1

13.5

SGC00

NOMESCO Finland

Local medication of root channels of tooth

2.0

13.5

178

925

B01AA03

ATC

warfarin; systemic

1.9

13.5

223

1258

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.6

13.5

168

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.8

13.4

319

L50.3

ICD-10 Finland

Dermatographic urticaria

4.8

13.4

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

7.4

13.4

R52.1

ICD-10 Finland

Chronic intractable pain

18.2

13.3

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.0

13.3

178

930

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

13.3

265

1590

K14.69

ICD-10 Finland

Tongue pain UNS

11.5

13.2

A02BX02

ATC

sucralfate; oral

3.3

13.2

203

Z01.9

ICD-10 Finland

Special examination, unspecified

2.6

13.2

382

J01CA04

ATC

amoxicillin; systemic

1.5

13.1

1469

13085

SBA00

NOMESCO Finland

Microbiological examinations

3.5

13.1

173

P03

ICPC

Feeling depressed

2.0

13.0

180

950

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.3

13.0

206

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.5

13.0

103

425

JAH01

NOMESCO Finland

Laparoscopy

2.8

12.9

291

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

12.9

134

629

ELB10

NOMESCO Finland

Excision of minor salivary gland

19.0

12.8

SPAT1101

SPAT

Orthostatic test

3.2

12.8

208

M01AH01

ATC

celecoxib; oral (coxibs)

1.8

12.8

241

1421

M02AA10

ATC

ketoprofen; topical

1.8

12.7

217

1239

A06AC51

ATC

ispaghula, combinations; systemic

2.8

12.7

305

R10.2

ICD-10 Finland

Pelvic and perineal pain

4.2

12.7

112

L50.9

ICD-10 Finland

Urticaria, unspecified

2.8

12.7

306

N05BA06

ATC

lorazepam; systemic, sublingual

3.1

12.7

232

F43.0

ICD-10 Finland

Acute stress reaction

2.7

12.6

324

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.6

12.6

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

69.8

12.6

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

12.5

206

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.0

12.5

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

12.5

109

472

SPAT1053

SPAT

Memory test

2.0

12.5

164

852

K58

ICD-10 Finland

Irritable bowel syndrome

3.5

12.5

164

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.8

12.5

F48.0

ICD-10 Finland

Neurasthenia

17.3

12.5

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

12.4

138

668

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.6

12.4

346

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.8

12.3

140

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.4

12.3

105

450

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.8

12.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

12.3

349

D11

ICPC

Diarrhoea

1.9

12.3

197

1101

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.4

12.3

102

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

3.2

12.2

199

C08CA01

ATC

amlodipine; oral

1.6

12.2

402

2766

N03AX14

ATC

levetiracetam; systemic

5.0

12.2

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.4

12.2

107

465

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.1

12.2

117

K14.61

ICD-10 Finland

Glossodynia

9.0

12.2

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

12.2

363

WZC30

NOMESCO Finland

Teaching

1.9

12.2

192

1066

KH1AD

NOMESCO Finland

CT of urinary organs

3.7

12.1

147

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

12.1

157

809

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

12.1

328

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

4.4

12.1

WX290

NOMESCO Finland

Other blockade of nerve

1.4

12.1

744

5848

D06

ICPC

Abdominal pain localized other

2.1

12.1

135

655

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

12.4

12.1

M54.3

ICD-10 Finland

Sciatica

2.6

12.0

333

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.3

12.0

F43.29

ICD-10 Finland

Adaptation disorder UNS

4.2

12.0

109

JN4BD

NOMESCO Finland

Extensive body CT

2.1

12.0

131

631

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.9

12.0

247

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

12.0

187

1035

L12

ICPC

Hand/finger symptom/complaint

1.8

12.0

237

1418

P25

ICPC

Phase of life problem adult

2.7

11.9

318

T90

ICPC

Diabetes non-insulin dependent

1.7

11.9

272

1697

K08.3

ICD-10 Finland

Retained dental root

2.5

11.9

380

J01MA14

ATC

moxifloxacin; systemic

2.2

11.9

120

556

J01CA08

ATC

pivmecillinam; oral

1.4

11.9

650

4985

SPAT1216

SPAT

Assessment of functional ability

1.9

11.9

194

1091

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

11.9

215

1252

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.3

11.9

113

512

UJF92

NOMESCO Finland

Capsular endoscopy

3.8

11.8

130

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

11.8

478

3443

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.1

11.8

111

IGV01

NOMESCO Finland

Psychiatric network contact

5.0

11.8

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.9

11.7

126

H57.1

ICD-10 Finland

Ocular pain

3.2

11.7

194

C10AC01

ATC

colestyramine; oral

4.1

11.7

112

N06AX05

ATC

trazodone; oral

4.0

11.7

117

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

11.7

409

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.6

11.7

147

E000001

ATC

1.6

11.7

345

2311

XKD03

NOMESCO Finland

Urethral pressure profilometry

4.1

11.6

108

SPAT1324

SPAT

Screening procedure

0.5

11.6

113

2030

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.2

11.6

196

D07AC13

ATC

mometasone; topical

1.5

11.6

422

2970

JN4AD

NOMESCO Finland

Body CT examination

2.5

11.6

374

EBA00

NOMESCO Finland

Extraction of tooth

1.5

11.6

534

3955

R4190

NOMESCO Finland

Nutritional therapy

2.6

11.6

348

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

11.5

163

871

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.0

11.5

230

L15

ICPC

Knee symptom/complaint

1.6

11.5

313

2048

M02AA07

ATC

piroxicam; topical

1.5

11.5

487

3541

N06AA06

ATC

trimipramine; systemic

4.1

11.5

109

M01AC06

ATC

meloxicam; systemic, rectal

1.5

11.5

493

3594

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.9

11.5

119

K92.1

ICD-10 Finland

Melaena

2.9

11.5

253

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

11.5

164

879

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.7

11.5

134

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.3

11.4

176

79199

ICD-8 Finland

Headache

+∞

11.4

N05AX12

ATC

aripiprazole; systemic

2.8

11.4

254

WZA90

NOMESCO Finland

Other doctors statement

1.5

11.4

396

2755

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.6

11.3

310

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

11.3

272

1721

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.0

11.3

111

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.6

11.3

141

B03BA03

ATC

hydroxocobalamin; parenteral

2.7

11.3

287

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

11.3

348

N05BE01

ATC

buspirone; oral

3.6

11.3

136

SPAT1325

SPAT

Vaccination

1.5

11.2

574

4335

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.8

11.2

264

A04AA01

ATC

ondansetron; systemic, rectal

2.4

11.2

398

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

4.8

11.2

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.3

11.2

SPAT1281

SPAT

Other administrative function

2.0

11.2

138

700

G04CA02

ATC

tamsulosin; oral

1.8

11.1

218

1299

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.0

11.1

211

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

11.1

364

WX204

NOMESCO Finland

Axillary plexus blockaced

3.4

11.1

159

SPAT1097

SPAT

Recording of ECG

1.8

11.1

187

1065

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

6.4

11.0

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.6

11.0

322

N07BB01

ATC

disulfiram; oral

3.0

10.9

215

N07CA01

ATC

betahistine; oral

2.3

10.9

431

M01AH02

ATC

rofecoxib; oral

1.9

10.9

165

904

F32

ICD-10 Finland

Depressive episode

2.3

10.9

100

444

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

10.8

131

659

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

4.6

10.8

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.0

10.8

106

G04BD12

ATC

mirabegron; oral

2.1

10.8

126

623

A10AE04

ATC

insulin glargine; parenteral

2.1

10.7

124

612

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

8.2

10.7

R99

ICPC

Respiratory disease other

4.9

10.7

A03

ICPC

Fever

1.6

10.7

302

1992

B37.0

ICD-10 Finland

Candidal stomatitis

6.5

10.7

N04BC05

ATC

pramipexole; oral

2.3

10.7

441

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.7

10.7

122

R06.4

ICD-10 Finland

Hyperventilation

4.7

10.6

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

10.6

226

SPAT1265

SPAT

Breathalyser

7.5

10.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

10.6

106

490

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

12.9

10.6

F44.4

ICD-10 Finland

Dissociative motor disorders

59.8

10.6

R06AE09

ATC

levocetirizine; oral

1.7

10.6

242

1508

P29

ICPC

Psychological sympt/compl other

2.2

10.6

113

537

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

10.6

329

2223

H93.1

ICD-10 Finland

Tinnitus

2.3

10.6

446

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.1

10.5

182

XLA10

NOMESCO Finland

2.4

10.5

387

N76.0

ICD-10 Finland

Acute vaginitis

2.1

10.5

111

529

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.0

10.5

194

D01

ICPC

Abdominal pain/cramps general

1.8

10.5

192

1120

L16

ICPC

Ankle symptom/complaint

1.8

10.4

171

963

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

10.4

140

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

10.4

242

1514

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.6

10.4

281

L86

ICPC

Back syndrome with radiating pain

2.4

10.4

362

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

7.3

10.4

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

109.7

10.4

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.7

10.4

120

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.8

10.4

241

C08CA05

ATC

nifedipine; systemic

2.4

10.4

364

P74

ICPC

Anxiety disorder/anxiety state

2.6

10.3

300

K08.80

ICD-10 Finland

Toothache NOS

2.0

10.3

131

671

A46

ICD-10 Finland

Erysipelas

1.9

10.3

162

897

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

10.3

129

659

L13

ICPC

Hip symptom/complaint

1.7

10.2

200

1191

R06.5

ICD-10 Finland

Mouth breathing

2.1

10.2

122

610

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

5.3

10.2

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

10.2

219

1341

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

10.1

271

1764

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

10.1

225

1391

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.3

10.1

155

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

10.1

131

677

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.4

10.0

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.6

10.0

G54.0

ICD-10 Finland

Brachial plexus disorders

3.3

10.0

150

J30.3

ICD-10 Finland

Other allergic rhinitis

2.5

10.0

301

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

10.0

206

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

10.0

139

739

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

3.4

10.0

140

R06.2

ICD-10 Finland

Wheezing

2.4

10.0

359

K29.7

ICD-10 Finland

Gastritis, unspecified

3.3

10.0

151

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.2

9.9

162

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

9.9

102

479

C05AA08

ATC

fluocortolone; rectal, topical

1.7

9.9

192

1139

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.8

9.9

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.1

9.9

115

569

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

9.9

374

N06AG02

ATC

moclobemide; oral

2.7

9.9

248

R06AX26

ATC

fexofenadine; oral

2.1

9.8

111

544

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.1

9.8

169

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

16.7

9.8

M35.7

ICD-10 Finland

Hypermobility syndrome

4.3

9.8

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

9.8

329

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

9.8

184

1082

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

9.8

165

938

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

9.7

100

467

KDE20

NOMESCO Finland

Removal of foreign body from urethra

10.6

9.7

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.6

9.7

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

8.7

9.7

C09CA06

ATC

candesartan; oral

1.6

9.7

274

1804

F61.0

ICD-10 Finland

Mixed personality disorders

4.2

9.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.1

9.7

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

6.5

9.7

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.9

9.6

SPAT1210

SPAT

Application of cast or individual aid

2.5

9.6

306

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.3

9.6

139

J37.0

ICD-10 Finland

Chronic laryngitis

3.1

9.6

172

M10.9

ICD-10 Finland

Gout, unspecified

2.6

9.6

272

R05

ICPC

Cough

1.5

9.6

348

2437

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.6

9.6

265

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.3

9.5

140

R03BA02

ATC

budesonide; inhalant

1.6

9.5

265

1742

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

9.5

469

R06AX22

ATC

ebastine; oral

1.6

9.5

260

1701

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

3.0

9.5

174

R4180

NOMESCO Finland

Podiatric therapy

6.0

9.4

M48.0

ICD-10 Finland

Spinal stenosis

1.9

9.4

129

682

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

4.4

9.4

XJH00

NOMESCO Finland

Transanal ultrasonography

2.5

9.4

288

N30

ICD-10 Finland

Cystitis

2.0

9.4

124

647

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

9.3

147

816

J46

ICD-10 Finland

Status asthmaticus

3.3

9.3

137

R39.1

ICD-10 Finland

Other difficulties with micturition

3.3

9.3

137

IGP01

NOMESCO Finland

Psychiatric family contact

3.8

9.3

101

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.7

9.3

106

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.2

9.3

C09AA05

ATC

ramipril; oral

1.6

9.3

264

1741

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

9.3

145

803

Z50.0

ICD-10 Finland

Cardiac rehabilitation

5.5

9.3

K04.0

ICD-10 Finland

Pulpitis

1.8

9.3

157

892

J01FA15

ATC

telithromycin; oral

1.9

9.2

146

810

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

9.2

372

R01AD05

ATC

budesonide; nasal

2.0

9.2

121

629

S01XA18

ATC

ciclosporin; ophthalmic

10.6

9.2

L30.3

ICD-10 Finland

Infective dermatitis

2.8

9.2

210

L19

ICPC

Muscle symptom/complaint NOS

3.3

9.2

133

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.7

9.2

176

1043

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

4.5

9.2

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.4

9.2

J01MA06

ATC

norfloxacin; oral

1.7

9.2

192

1166

WZA10

NOMESCO Finland

Long statement of health and health related matters

4.3

9.1

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.4

9.1

129

SPAT1285

SPAT

Provision of consultation response

2.2

9.1

397

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.1

9.1

105

518

R4120

NOMESCO Finland

Occupational therapy

2.2

9.1

423

F34.1

ICD-10 Finland

Dysthymia

2.7

9.1

230

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

9.0

157

900

L14

ICPC

Leg/thigh symptom/complaint

2.1

9.0

103

508

P06

ICPC

Sleep disturbance

1.8

9.0

146

817

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.3

9.0

D10

ICPC

Vomiting

2.0

9.0

119

618

T82

ICPC

Obesity

2.6

9.0

245

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.8

9.0

208

F61

ICD-10 Finland

Mixed and other personality disorders

10.0

9.0

NG1DA

NOMESCO Finland

X-ray of knees

4.0

9.0

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

8.9

209

1313

M01AX17

ATC

nimesulide; oral

1.5

8.9

295

2024

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.0

8.8

160

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

8.8

155

893

A28

ICPC

Limited function/disability NOS

1.8

8.8

153

879

A78

ICPC

Infectious disease other/NOS

3.2

8.8

144

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.2

8.8

371

L17

ICPC

Foot/toe symptom/complaint

1.5

8.8

373

2698

L04

ICPC

Chest symptom/complaint

2.2

8.7

396

D93

ICPC

Irritable bowel syndrome

4.9

8.7

Y34

ICD-10 Finland

Unspecified event, undetermined intent

10.7

8.7

WX730

NOMESCO Finland

Conventional respirator

4.3

8.7

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.6

8.7

231

D09

ICPC

Nausea

2.1

8.7

444

R10.0

ICD-10 Finland

Acute abdomen

2.9

8.7

178

G03DC03

ATC

lynestrenol; oral

3.1

8.7

145

G04BD08

ATC

solifenacin; oral

2.2

8.7

377

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

8.7

458

D02

ICPC

Abdominal pain epigastric

2.2

8.7

411

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

49.8

8.6

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.4

8.6

296

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

8.6

114

OAB72

NOMESCO Finland

Weight control and weight loss guidance

7.6

8.6

C01DA14

ATC

isosorbide mononitrate; oral

1.8

8.6

144

817

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.6

8.6

104

3007

Kela drug reimbursment

Erenumab and fremanezumab

5.2

8.5

Z00.0

ICD-10 Finland

General medical examination

1.5

8.5

277

1888

SPAT1043

SPAT

Audiometry

1.8

8.5

151

874

L02

ICPC

Back symptom/complaint

1.8

8.5

140

789

R96

ICPC

Asthma

1.9

8.5

125

678

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

6.9

8.5

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

10.0

8.5

N48.1

ICD-10 Finland

Balanoposthitis

3.3

8.5

126

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

8.5

109

564

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.9

8.4

R04.2

ICD-10 Finland

Haemoptysis

3.2

8.4

132

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

8.4

349

2509

P15

ICPC

Chronic alcohol abuse

3.4

8.4

111

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.4

8.4

111

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.1

8.4

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

8.4

149

XX9TE

NOMESCO Finland

Compementary ultrasound examination

7.3

8.4

F10.24

ICD-10 Finland

Alcohol depence active use

5.3

8.4

K92.0

ICD-10 Finland

Haematemesis

3.6

8.4

101

F31

ICD-10 Finland

Bipolar affective disorder

4.7

8.4

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.4

8.3

280

N20.1

ICD-10 Finland

Calculus of ureter

2.9

8.3

172

R56.0

ICD-10 Finland

Febrile convulsions

+∞

8.3

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

8.3

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

+∞

8.3

UJD02

NOMESCO Finland

Gastroscopy

2.5

8.3

251

L29.9

ICD-10 Finland

Pruritus, unspecified

3.2

8.3

128

G50.0

ICD-10 Finland

Trigeminal neuralgia

4.8

8.3

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

8.3

568

4476

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.6

8.3

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.1

8.2

140

XJC10

NOMESCO Finland

Oesophageal pH monitoring

5.8

8.2

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

8.2

109

570

E000006

ATC

1.9

8.2

109

571

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.4

8.2

108

H92.0

ICD-10 Finland

Otalgia

2.1

8.2

465

M43.1

ICD-10 Finland

Spondylolisthesis

2.7

8.1

205

R12

ICD-10 Finland

Heartburn

2.0

8.1

494

SPAT1341

SPAT

Referral to physician or dentist

4.9

8.1

J34.2

ICD-10 Finland

Deviated nasal septum

2.3

8.1

318

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

8.1

199

ZXC50

NOMESCO Finland

Cryotherapy

3.1

8.1

142

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.7

8.0

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

8.1

8.0

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

8.1

8.0

TJD20

NOMESCO Finland

Change of gastrostomy tube

11.6

8.0

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

11.6

8.0

U07

ICPC

Urine symptom/complaint other

2.2

8.0

366

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

8.0

489

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

8.0

313

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

6.8

8.0

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.5

8.0

244

R25.1

ICD-10 Finland

Tremor, unspecified

3.1

8.0

132

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.8

8.0

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

8.0

442

J01

ICD-10 Finland

Acute sinusitis

2.2

7.9

382

R01AD11

ATC

triamcinolone; nasal

1.8

7.9

128

719

I95.1

ICD-10 Finland

Orthostatic hypotension

3.4

7.9

106

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

7.9

105

551

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

7.9

383

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.6

7.9

206

N06AA12

ATC

doxepin; systemic

2.3

7.9

297

R4130

NOMESCO Finland

Speech therapy

3.1

7.9

128

A02BA03

ATC

famotidine; systemic

2.6

7.9

207

R06AX13

ATC

loratadine; oral

1.6

7.9

231

1536

L20.0

ICD-10 Finland

Besnier prurigo

1.8

7.8

143

833

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

13.0

7.8

K12.18

ICD-10 Finland

Other forms of stomatitis

6.6

7.8

J96.0

ICD-10 Finland

Acute respiratory failure

6.6

7.8

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.0

7.8

140

SPAT1181

SPAT

Ultrasound examination of uterus and uterine appendages

2.5

7.8

226

SPAT1094

SPAT

Continuous Positive Airway Pressure

5.1

7.8

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

7.8

426

3223

A99

ICPC

Disease/condition unspecnature/site

1.9

7.8

112

606

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

5.7

7.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

7.8

210

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.4

7.8

273

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.0

7.8

509

G04BD04

ATC

oxybutynin; oral, transdermal

2.3

7.7

313

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

7.7

305

A06AX04

ATC

linaclotide; oral

9.4

7.7

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

7.7

499

XG405

NOMESCO Finland

Education on PEF monitoring

4.0

7.7

M01AX01

ATC

nabumetone; oral

2.5

7.7

237

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.3

7.7

109

SPAT1079

SPAT

Echocardiography

5.0

7.7

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.3

7.7

S80.0

ICD-10 Finland

Contusion of knee

2.0

7.6

501

E86

ICD-10 Finland

Volume depletion

4.2

7.6

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.9

7.6

152

WX400

NOMESCO Finland

Inhalation anesthesy

2.1

7.6

424

EBA30

NOMESCO Finland

Excision of root of tooth

2.3

7.6

300

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.6

7.6

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

7.6

110

595

R10

ICD-10 Finland

Abdominal and pelvic pain

3.8

7.6

TK800

NOMESCO Finland

Hemodialysis

3.8

7.6

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.3

7.6

110

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.5

7.6

225

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.6

670

5479

A05

ICPC

Feeling ill

1.8

7.6

137

796

C10AA01

ATC

simvastatin; oral

1.4

7.6

457

3513

I49

ICD-10 Finland

Other cardiac arrhythmias

4.2

7.5

K11.2

ICD-10 Finland

Sialoadenitis

2.8

7.5

167

RD210

NOMESCO Finland

2.9

7.5

148

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

7.5

317

U02

ICPC

Urinary frequency/urgency

1.6

7.5

188

1204

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.6

7.4

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.7

7.4

186

WVA20

NOMESCO Finland

Medicine administration

3.5

7.4

SPAT1360

SPAT

Extensive global examination

1.9

7.4

101

536

N41.1

ICD-10 Finland

Chronic prostatitis

4.0

7.4

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

7.4

1479

13603

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

7.4

105

566

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

7.4

241

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.0

7.4

456

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

7.4

173

J02AC02

ATC

itraconazole; systemic

1.5

7.4

244

1667

XA421

NOMESCO Finland

Nocturnal polygraphy

13.3

7.3

RL140

NOMESCO Finland

13.3

7.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

7.3

100

528

A10BA02

ATC

metformin; oral

1.5

7.3

312

2250

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

7.3

292

S29

ICPC

Skin symptom/complaint other

1.5

7.3

238

1618

L04AX01

ATC

azathioprine; systemic

2.2

7.3

302

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.5

7.3

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.5

7.3

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.9

7.3

104

561

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

7.3

244

SPAT1395

SPAT

Health check-up of persons outside student and working life

3.0

7.3

136

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40761536) Microorganisms panel - Urine sediment

561

1251

5.67

243.83

5.3

3.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

495

1266

4.74

178.84

4.0

2.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

467

1186

4.71

169.59

2.5

2.0

359.9

379.2

nmol/l

1.31

440

1094

(3021589) Normoblasts [#/volume] in Blood

1383

7319

3.50

164.94

14.0

7.2

0.0

e9/l

0.88

1214

5868

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

405

976

4.84

156.17

3.7

2.9

1.2

mmol/l

0.19

346

826

(3018418) pH of Serum or Plasma

879

3685

3.32

151.58

4.2

3.3

7.4

0.64

327

648

(42870588) Differential panel, method unspecified - Blood

1075

5204

3.11

142.70

6.3

5.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

800

3412

3.12

130.28

2.5

1.8

154.1

241.4

u/l

2.22

761

3198

(3010421) pH of Blood

188

256

7.87

130.23

4.2

3.7

7.4

0.17

168

208

(3012501) Base excess in Blood by calculation

171

211

8.63

128.60

4.4

3.9

2.4

2.5

mmol/l

0.13

126

132

(1616796) Gas panel - Central venous blood

169

208

8.65

127.34

3.6

3.1

—

(3037522) Nuclear Ab [Titer] in Serum

556

1947

3.47

125.22

1.6

1.3

427.4

542.0

titre

0.86

136

378

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1219

6672

2.90

123.73

7.7

6.0

1.2

mmol/l

0.03

895

5711

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1144

6060

2.88

123.49

7.9

5.6

1.2

mmol/l

0.34

1061

5488

(3012095) Magnesium [Moles/volume] in Serum or Plasma

538

1897

3.42

119.26

3.9

3.6

0.8

mmol/l

0.17

509

1789

(3022096) Basophils/100 leukocytes in Blood

1256

7119

2.83

116.87

7.1

5.2

0.7

0.13

1208

6641

(3024561) Albumin [Mass/volume] in Serum or Plasma

1067

5594

2.78

115.10

4.9

4.3

36.2

36.3

g/l

0.41

1006

5189

(3006504) Eosinophils/100 leukocytes in Blood

1277

7383

2.78

112.86

7.1

5.2

2.7

3.0

3.75

1226

6867

(3019069) Monocytes/100 leukocytes in Blood

1283

7436

2.79

112.83

7.2

5.4

8.3

0.21

1238

6966

(40767503) Oxygen content in Capillary blood by calculation

154

198

8.22

111.76

2.7

2.0

17.3

17.2

0.14

102

(3015171) Extractable nuclear Ab [Units/volume] in Serum

247

518

5.21

110.82

1.4

1.3

0.3

1.2

u/ml

1.07

(3000850) Epithelial cells [#/volume] in Urine

661

2750

3.00

109.47

3.2

2.2

6.2

6.3

e6/l

0.04

570

2381

(3001604) Monocytes [#/volume] in Blood

1315

7802

2.75

108.94

7.0

5.1

0.6

e9/l

0.18

1184

6659

(3006315) Basophils [#/volume] in Blood

1317

7825

2.75

108.70

7.0

5.1

0.0

e9/l

0.38

1182

6672

(3002030) Lymphocytes/100 leukocytes in Blood

1303

7725

2.73

107.58

7.1

5.2

29.7

30.3

1.03

1257

7221

(3032080) INR in Blood by Coagulation assay

956

4887

2.70

106.15

12.9

6.9

1.2

inr

0.22

527

1430

(3013826) Glucose [Moles/volume] in Serum or Plasma

1347

8176

2.72

105.09

6.9

4.1

6.4

6.5

mmol/l

0.88

1291

7447

(3026782) Osmolality of Urine

618

2535

2.99

104.32

3.4

2.4

512.0

557.2

mosm/kgh2o

4.82

532

2132

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

201

369

5.85

104.26

1.7

0.2

g/l

0.08

188

352

(3005719) IgG [Mass/volume] in Serum or Plasma

344

980

3.95

104.19

2.3

2.6

10.4

10.3

g/l

0.24

308

890

(3019198) Lymphocytes [#/volume] in Blood

1334

8087

2.70

103.83

7.0

5.1

2.0

e9/l

0.04

1217

7065

(3013115) Eosinophils [#/volume] in Blood

1338

8127

2.70

103.67

7.3

5.3

0.2

e9/l

2.49

1220

7078

(3030467) Casts [#/volume] in Urine by Automated count

797

3757

2.76

103.37

4.2

2.6

0.3

0.4

e6/l

0.60

623

2730

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

828

3989

2.73

102.76

3.3

2.1

55.8

57.5

u/l

0.24

753

3668

(3013707) Erythrocyte sedimentation rate by Westergren method

1675

11448

3.12

102.66

5.6

3.4

10.9

10.5

mm/h

0.74

1576

10561

(36304419) Bacteria [Presence] in Urine

789

3727

2.74

101.58

4.2

2.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

754

3481

2.77

101.53

5.0

3.7

—

(3002582) Erythrocytes [#/volume] in Urine

839

4090

2.70

101.44

4.2

2.7

153.8

83.3

e6/l

0.32

669

3040

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

204

390

5.62

101.27

1.7

1.6

1.2

g/l

0.47

192

369

(3029937) Albumin [Presence] in Urine by Test strip

810

3910

2.70

99.49

5.2

3.2

0.0

estimate

0.07

452

1304

(3041096) Erythrocytes [Presence] in Urine by Automated

844

4165

2.67

99.07

4.8

2.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1642

11242

2.97

97.43

8.7

5.8

83.0

80.2

u/l

1.17

1546

10506

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

882

4481

2.62

97.13

4.6

2.7

29.0

47.5

ng/l

0.96

547

2608

(3013650) Neutrophils [#/volume] in Blood by Automated count

1415

9012

2.66

96.49

9.4

7.2

4.0

3.9

e9/l

0.50

1283

7737

(3018010) Neutrophils/100 leukocytes in Blood

1262

7620

2.57

96.12

6.9

5.0

55.9

55.2

1.05

1219

7148

(3035350) Ketones [Presence] in Urine by Test strip

1241

7454

2.56

95.26

4.8

3.0

0.0

estimate

0.80

456

1310

(3037467) Urinalysis macro (dipstick) panel - Urine

1576

10638

2.81

94.61

5.7

3.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1240

7484

2.54

93.59

6.1

4.1

0.0

estimate

0.50

458

1336

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1174

6930

2.51

92.64

6.3

5.0

12.0

12.9

umol/l

0.78

1100

6518

(3009261) Glucose [Presence] in Urine by Test strip

1245

7555

2.52

92.45

4.8

3.0

0.0

estimate

1.32

442

1300

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

621

2738

2.76

89.74

2.0

1.6

31765171.4

29447490.3

pmol/l

0.03

510

2333

(3018095) Leukocytes [#/volume] in Urine

937

5051

2.49

89.16

4.8

3.1

76.2

74.8

e6/l

0.02

702

3322

(40768797) Stomach Pathology biopsy report

469

1812

3.00

86.40

1.4

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

514

2094

2.88

85.91

2.6

2.4

128.4

109.2

ug/g

0.51

393

1652

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

645

2970

2.65

84.81

2.3

1.7

1.2

mg/l

0.05

471

2214

(3031040) Bacteria [#/volume] in Urine by Automated count

1489

10074

2.55

83.48

6.5

3.5

92.6

2242.5

e6/l

—

117

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

584

2583

2.71

83.02

1.5

1.2

24.0

30.6

iu/ml

0.80

175

826

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

148

255

6.10

81.67

3.1

3.5

55.9

56.4

0.18

148

255

(3030905) Polymorphonuclear cells [#/volume] in Blood

144

249

6.06

79.15

2.9

3.4

3.8

3.9

e9/l

0.15

144

249

(3044889) 12 lead EKG panel

1478

10109

2.47

78.46

4.5

3.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

840

4518

2.39

77.78

2.9

2.4

mmol/l

0.50

759

3961

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

274

827

3.61

75.18

1.4

1.3

45.3

45.0

au/ml

0.01

(3023368) Bacteria identified in Blood by Culture

632

3030

2.51

75.02

5.0

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

989

5772

2.30

74.97

5.0

3.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

260

763

3.70

74.37

1.9

1.7

1.5

1.3

g/l

0.28

238

702

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

420

1648

2.90

74.27

2.4

2.2

22.5

23.3

0.50

358

1421

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

290

919

3.46

73.76

2.5

2.3

23.5

22.2

au/ml

0.05

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1035

6236

2.25

71.68

2.7

2.2

77.2

75.5

nmol/l

1.04

961

5678

(3022948) Iron [Moles/volume] in Serum or Plasma

471

2004

2.70

71.07

2.4

2.1

13.2

13.9

umol/l

1.23

429

1870

(3025159) Blasts/100 leukocytes in Blood

300

1003

3.28

69.86

3.6

1.3

0.5

0.23

195

(3005322) IgE [Units/volume] in Serum or Plasma

323

1129

3.16

69.83

1.6

1.3

139.7

249.1

u/ml

2.67

313

1053

(3003458) Phosphate [Moles/volume] in Serum or Plasma

429

1757

2.77

69.61

5.5

5.4

1.1

mmol/l

0.99

398

1643

(3004789) Transferrin [Mass/volume] in Serum or Plasma

437

1807

2.75

69.60

2.4

2.1

2.5

2.4

g/l

0.61

390

1680

(3007164) IgA [Mass/volume] in Serum or Plasma

686

3518

2.37

69.25

1.7

1.4

2.1

g/l

0.89

428

2034

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

168

377

4.70

68.86

1.4

1.2

32.4

47.7

u/ml

0.28

(3021440) Promyelocytes/100 leukocytes in Blood

306

1051

3.20

68.06

3.6

0.1

0.36

229

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1171

7518

2.21

68.04

3.6

2.6

96.5

91.0

ug/l

0.48

1071

7031

(3002179) Metamyelocytes/100 leukocytes in Blood

295

996

3.24

67.49

3.4

0.5

0.08

176

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

146

296

5.17

67.45

1.3

1.2

36.2

37.1

u/ml

0.02

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1709

12884

2.60

67.10

5.5

3.7

14.8

14.6

pmol/l

2.20

1593

11774

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

762

4132

2.29

67.10

1.5

1.4

2.3

2.0

u/ml

0.19

228

1042

(3017181) Myelocytes/100 leukocytes in Blood

311

1092

3.13

66.56

3.6

3.5

1.0

0.8

0.49

252

(3020630) Protein [Mass/volume] in Serum or Plasma

253

784

3.49

66.37

2.0

2.5

67.5

66.9

g/l

0.67

233

720

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

694

3639

2.32

65.98

2.7

2.2

2.8

2.9

mg/l

0.26

609

3119

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

187

484

4.09

63.67

1.8

1.9

38.2

39.7

u/l

0.42

176

440

(3013512) EKG study

677

3597

2.27

61.64

4.3

3.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

514

2462

2.41

59.28

1.4

1.2

9.3

11.9

u/ml

0.37

190

1003

(3000570) Elastase.pancreatic [Mass/mass] in Stool

148

339

4.57

59.02

1.4

315.6

318.1

ug/g

0.04

180

(3019309) Folate [Moles/volume] in Red Blood Cells

464

2126

2.48

58.98

2.1

1.7

1337.6

1173.8

nmol/l

2.81

365

1599

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

590

3029

2.28

57.74

3.0

2.8

1587.8

1217.0

ng/l

0.45

480

2528

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

411

1809

2.55

56.72

2.1

1.6

—

(3026008) Bacteria identified in Urine by Culture

727

4085

2.16

56.68

4.3

2.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1966

16366

3.56

56.02

21.3

10.8

139.5

139.7

mmol/l

2.81

1932

15861

(3004588) Protein electrophoresis panel - Serum or Plasma

204

615

3.52

55.56

1.6

2.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1968

16412

3.56

55.50

21.4

10.9

3.9

mmol/l

0.04

1931

15869

(3022145) Colonoscopy Study observation

359

1524

2.60

53.15

1.4

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1980

16667

3.61

52.95

20.3

9.3

18.1

22.8

mg/l

10.82

1671

12335

(3044290) Cell count panel - Cerebral spinal fluid

109

211

5.33

52.94

1.9

2.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

121

257

4.88

52.83

1.8

1.7

413.2

524.3

mg/l

1.98

115

245

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

161

428

3.94

52.66

2.0

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

559

2901

2.23

52.61

1.6

1.4

20.3

21.0

nmol/l

0.48

473

2475

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

142

346

4.28

52.25

1.3

5.4

8.5

u/ml

0.42

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

114

234

5.04

51.80

1.9

2.0

13.4

16.6

e6/l

0.20

170

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

114

234

5.04

51.80

1.9

2.0

1189.5

19343.9

e6/l

0.57

180

(3021901) Oxygen saturation in Capillary blood

179

5.69

51.77

2.7

2.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

139

341

4.24

50.67

1.3

26.0

2.3

u/ml

0.60

(3000494) Fungus identified in Specimen by Culture

366

1604

2.52

50.53

1.7

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

196

614

3.38

50.15

8.3

5.7

8.9

9.2

kpa

1.41

188

582

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

121

270

4.64

49.76

1.2

1.3

1.0

2.2

u/ml

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

110

230

4.93

48.90

1.7

3.8

3.6

mmol/l

0.44

101

221

(3006184) Hemoglobin [Mass/volume] in Capillary blood

112

240

4.82

48.36

2.3

2.1

134.8

133.7

g/l

0.20

179

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

299

1220

2.66

47.67

3.1

3.8

266.4

253.4

u/l

0.26

291

1155

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

788

4805

1.99

47.36

3.4

2.9

33.6

30.9

u/l

0.54

736

4565

(4062490)

132

6.27

47.09

1.7

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

394

1851

2.36

46.36

2.8

2.5

30.5

29.9

1.17

382

1797

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

853

5387

1.95

45.93

2.1

1.8

97.1

97.2

pmol/l

0.03

457

2764

(3002385) Erythrocyte distribution width [Ratio]

1788

14563

2.36

45.83

22.6

12.0

13.5

0.28

1766

14222

(3028192) IgG subclass 2 [Mass/volume] in Serum

130

6.20

45.48

1.7

1.3

2.7

2.8

g/l

0.19

(3024139) IgG subclass 3 [Mass/volume] in Serum

130

6.20

45.48

1.7

1.3

0.4

g/l

0.43

(3003327) Ova and parasites identified in Stool by Light microscopy

174

539

3.39

45.23

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

131

6.16

45.13

1.7

1.3

6.6

6.7

g/l

0.06

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

213

757

2.98

43.94

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

132

6.03

43.66

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

136

366

3.86

43.63

1.7

1.6

68.6

181.3

titre

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

289

1211

2.57

43.44

2.0

1.5

—

(3042631) Mycobacterium sp identified in Specimen

114

6.43

43.04

2.5

2.8

—

(3025941) Bacteria identified in Stool by Culture

225

835

2.86

42.88

1.4

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

126

329

3.96

42.16

1.9

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

271

1117

2.60

42.08

7.4

6.5

7.9

8.4

mmol/l

0.52

261

1075

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

289

1231

2.53

41.91

2.1

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

103

6.61

41.20

1.6

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1396

10574

1.89

40.88

4.1

2.7

44.0

38.1

u/l

2.24

1294

9976

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

8.89

40.58

1.5

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

110

268

4.23

40.40

2.9

3.2

24.4

mmol/l

0.01

105

231

(3016018) Differential panel - Cerebral spinal fluid

119

6.07

40.12

1.9

2.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

148

5.44

39.74

1.6

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

238

955

2.65

38.90

3.6

3.3

4.5

4.6

pmol/l

1.39

218

853

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

433

2261

2.12

38.72

2.8

2.6

2.4

mmol/l

0.60

372

1958

(3024980) IgG subclass 4 [Mass/volume] in Serum

206

4.62

38.55

2.0

1.4

0.6

0.7

g/l

0.56

160

(3014111) Lactate [Moles/volume] in Serum or Plasma

242

990

2.60

38.01

9.3

8.7

1.3

mmol/l

0.11

233

943

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

134

5.54

37.53

1.3

1.2

0.1

0.8

u/ml

0.75

(3026493) Urate [Moles/volume] in Serum or Plasma

574

3360

1.95

37.15

2.7

2.3

2555.7

6207.7

umol/l

1.54

486

2964

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1809

15192

2.20

36.68

6.5

4.3

1.9

2.1

mu/l

0.81

1699

14055

(3020961) Endomysium IgA Ab [Titer] in Serum

239

990

2.56

36.54

1.2

455.0

233.3

titre

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

247

1041

2.52

36.41

7.5

5.0

1.2

1.3

mmol/l

0.03

169

749

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1756

14604

2.10

36.17

18.4

8.9

87.4

86.1

ml/min/173m2

1.36

1570

11589

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

101

6.22

36.04

1.1

—

(3009343) pH of Capillary blood

249

1059

2.50

35.99

7.4

5.0

7.4

1.06

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

250

1066

2.50

35.94

7.4

5.0

5.1

kpa

0.60

239

1007

(3026389) Candida sp identified in Specimen by Organism specific culture

186

4.67

35.76

1.4

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

6.27

35.14

1.1

1.0

209.1

225.2

mg/l

0.42

(40758558) Short blood count panel - Blood

640

3946

1.87

34.99

6.3

5.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

419

2242

2.06

34.74

4.8

3.0

294.0

634.6

ng/l

2.15

273

1591

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

102

6.06

34.55

1.2

1.1

27.5

35.9

mg/l

1.56

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

270

1217

2.37

34.28

2.2

2.5

0.2

g/l

0.06

255

1155

(4027681)

6.87

33.93

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

279

1292

2.31

33.24

1.4

1.2

145.9

167.9

iu/ml

0.36

481

(3023410) Appearance of Cerebral spinal fluid

119

5.45

32.46

2.3

2.5

—

(3033658) Prothrombin time (PT) actual/Normal

579

3543

1.85

31.93

5.3

3.5

90.0

92.1

1.22

567

3459

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

145

4.90

31.44

1.3

0.5

0.6

nmol/l

1.13

140

(3027945) Reticulocytes/100 erythrocytes in Blood

290

1396

2.22

31.40

2.8

2.7

1.6

1.7

0.06

257

1246

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

7.18

31.39

1.1

1.2

0.1

7.5

nmol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

166

625

2.77

30.57

1.3

—

(3000492) Spirometry study

303

1505

2.16

30.27

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1974

17506

2.65

30.23

13.0

8.0

25.2

25.4

u/l

0.13

1915

16862

(3023520) Reticulocytes [#/volume] in Blood

225

990

2.40

30.02

2.8

2.6

70.4

69.2

e9/l

0.13

156

702

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

114

5.33

29.72

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

239

3.85

29.38

1.6

—

(40768804) Tissue Pathology biopsy report

872

6132

1.69

28.98

2.1

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

669

4376

1.75

28.97

3.2

7.5

7.8

mmol/l

0.85

543

3735

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

103

303

3.48

28.92

2.7

2.3

1501.1

532.5

ug/l

0.53

283

(3007853) Bacteria identified in Skin by Aerobe culture

322

1672

2.07

28.53

1.8

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

256

1219

2.22

28.33

3.2

2.0

29.6

80.9

u/l

0.71

209

1029

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

612

3928

1.76

28.19

1.7

1.6

1.4

1.3

mmol/l

1.41

407

3380

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

6.53

28.17

1.1

1.0

1.2

u/l

0.70

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

276

3.56

27.92

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

195

837

2.44

27.42

5.6

4.4

23.9

23.6

mmol/l

0.75

189

786

(3004616) Nuclear Ab [Presence] in Serum

135

4.73

27.20

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

381

2135

1.93

27.09

4.0

2.5

2.8

e6/l

0.06

215

1142

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

297

1526

2.08

26.99

2.9

2.7

5.8

7.0

umol/l

0.91

240

1313

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

210

939

2.35

26.93

3.7

4.1

71.6

75.7

ng/l

0.47

178

838

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

236

3.71

26.80

2.4

2.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

238

3.68

26.47

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

627

4113

1.72

26.42

2.0

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

264

3.52

26.11

1.6

1.5

100.0

103.8

u/ml

0.15

(40761511) CBC panel - Blood by Automated count

1970

17646

2.45

26.01

19.0

9.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

137

4.50

24.88

1.3

—

(3042936) Bacteria identified in Isolate by Culture

329

1804

1.95

24.78

1.9

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

341

3.12

24.53

1.4

2.6

2.9

3.1

g/l

1.15

272

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

8.07

24.44

1.5

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

8.07

24.44

1.5

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.22

24.07

1.0

1.3

88.8

74.2

1.52

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

8.22

24.07

1.0

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

341

3.09

23.90

1.4

2.6

10.4

g/l

0.02

292

(3021447) Carbon dioxide [Partial pressure] in Venous blood

253

1281

2.08

23.77

5.3

4.2

5.8

5.7

kpa

0.64

245

1249

(3002032) Base excess in Venous blood by calculation

253

1281

2.08

23.77

5.3

4.2

1.4

mmol/l

0.06

213

969

(3023323) Follitropin [Units/volume] in Serum or Plasma

218

1043

2.19

23.71

1.5

1.4

21.3

24.3

iu/l

0.75

180

860

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

364

3.01

23.69

1.4

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

364

3.01

23.69

1.4

2.5

7.4

g/l

0.00

279

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1741

15049

1.80

23.53

4.6

3.8

5.8

mmol/l

0.88

1609

13806

(3009466) Valproate [Moles/volume] in Serum or Plasma

156

4.15

23.51

6.5

5.2

355.7

375.1

umol/l

0.47

132

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

387

2273

1.84

23.50

3.9

2.3

0.9

1.3

e6/l

0.95

222

1272

(3021387) Prolactin [Units/volume] in Serum or Plasma

174

762

2.37

23.33

2.0

1.6

316.3

309.2

mu/l

0.10

149

685

(3035637) Corticotropin [Mass/volume] in Plasma

185

3.84

23.03

1.8

1.5

—

(3000991) Gas panel - Venous blood

237

1187

2.10

22.89

12.5

8.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

105

364

2.95

22.49

1.4

2.5

3.6

3.9

g/l

1.62

263

(3003181) Sodium [Moles/volume] in Urine

166

3.96

22.44

1.7

2.3

70.1

69.6

mmol/l

0.02

135

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

313

3.10

22.23

1.4

1.3

228.5

243.4

u/ml

0.24

168

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.75

22.21

1.4

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

172

3.88

22.16

1.3

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1626

13872

1.68

22.00

5.8

4.8

39.0

38.8

mmol/mol

0.37

1515

12947

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

9.00

21.80

1.1

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

559

3714

1.66

21.73

2.0

1.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

222

1107

2.10

21.66

5.2

4.0

4.9

kpa

0.12

216

1079

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

100

4.83

21.45

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

100

4.83

21.45

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

100

4.83

21.45

1.2

1.1

—

(3002256) Pathology report gross observation

329

1886

1.86

21.44

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

101

4.79

21.20

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

101

4.79

21.20

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

101

4.79

21.20

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

280

3.16

21.19

1.5

2.5

0.0

g/l

0.92

256

(3023183) Ammonium ion [Moles/volume] in Plasma

227

3.40

20.88

2.2

3.0

29.8

34.1

umol/l

1.20

201

(3012516) Albumin [Mass/volume] in Urine

558

3738

1.65

20.87

3.3

3.2

587.0

233.4

mg/l

0.69

328

2348

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

278

3.15

20.79

1.4

1.3

—

15.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

5.59

20.56

1.4

5.6

7.1

u/l

0.62

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

333

2.94

20.55

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

317

2.99

20.53

1.5

2.6

1.2

1.1

g/l

0.04

276

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

130

4.19

20.19

1.3

—

nmol/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

289

3.06

20.09

1.5

2.4

38.2

37.9

g/l

0.17

251

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

264

3.16

19.97

1.5

2.5

0.0

g/l

0.00

242

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

265

3.14

19.84

1.5

2.5

0.0

g/l

0.00

242

(4035726)

218

1121

2.03

19.52

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

811

6013

1.54

19.38

3.2

2.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

342

2.80

18.46

1.9

1.8

1.4

2.0

ug/l

0.45

302

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

127

4.05

18.25

1.5

1.3

—

(3011985) Renin [Units/volume] in Plasma

141

3.86

18.11

1.2

1.4

73.9

103.3

mu/l

0.16

128

(3020682) Albumin/Creatinine [Ratio] in Urine

568

3935

1.58

18.09

5.0

3.9

7.6

8.0

mg/mmol

0.13

324

2483

(3023419) Bacteria identified in Sputum by Culture

129

3.98

17.88

2.6

3.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

184

918

2.08

17.86

2.7

2.1

2113.1

5071.4

u/l

1.76

358

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

138

3.87

17.85

1.2

1.5

360.2

406.9

pmol/l

0.16

108

(3019420) Tryptase [Mass/volume] in Serum or Plasma

4.63

17.48

1.6

1.8

4.8

8.4

ug/l

1.22

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.13

17.41

1.3

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

320

1932

1.75

17.32

1.9

1.6

1.5

1.4

2.87

266

1739

(3028707) Methadone [Presence] in Urine by Screen method

371

2.66

17.31

1.8

2.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

128

559

2.35

17.25

1.5

10.7

9.5

u/l

0.37

423

(3013139) Helicobacter pylori Ag [Presence] in Stool

191

982

2.02

17.07

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

6.17

16.96

1.7

1.4

0.9

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

5.92

16.28

1.2

1.1

0.3

g/l

0.66

(3017143) Hepatitis C virus Ab [Presence] in Serum

314

1919

1.73

16.21

1.6

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

3.33

16.14

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

203

3.18

16.02

1.4

1.3

—

(3011412) CD3 cells [#/volume] in Blood

115

3.93

15.58

2.1

1.5

1.4

e9/l

0.26

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

105

444

2.41

15.23

9.0

6.6

1.4

1.3

mg/l

0.43

421

(3040151) Glucose [Moles/volume] in Capillary blood

126

3.75

15.23

3.1

4.5

7.4

6.9

mmol/l

0.51

106

(3019060) Gas panel - Arterial blood

139

662

2.15

15.22

4.7

4.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

131

3.68

15.16

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

290

2.72

14.74

1.6

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.48

14.72

4.2

3.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1468

12665

1.48

14.68

4.1

3.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.16

14.61

2.2

1.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

132

627

2.15

14.55

1.7

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

517

2.27

14.51

1.2

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

189

1026

1.90

14.39

2.5

60.4

70.9

ml/min/173m2

2.57

382

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

100

4.01

14.28

2.1

1.9

10.0

11.0

0.27

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.22

14.21

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.95

14.12

1.1

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

350

2.52

14.06

1.3

1.2

1184.0

841.7

titre

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

286

2.69

14.05

1.6

1.2

—

(36660697) Celiac disease serology panel - Serum

250

1493

1.74

13.92

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

243

2.83

13.86

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

243

2.83

13.86

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

159

3.29

13.85

1.4

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

4.12

13.71

1.8

1.7

44.8

27.8

1.22

(3020393) Adenovirus Ag [Presence] in Stool

5.99

13.66

1.3

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

349

2.50

13.65

1.3

1.2

130.8

103.6

titre

0.22

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

5.53

13.63

1.2

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

374

2.44

13.58

3.6

2.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.92

13.37

1.2

1.1

—

(3003396) Base excess in Arterial blood by calculation

211

1216

1.80

13.26

11.4

8.1

1.5

0.8

mmol/l

1.45

177

940

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

115

541

2.17

13.01

1.4

1.3

—

(3007461) Platelets [#/volume] in Blood

2040

19213

2.30

12.78

28.8

14.4

261.9

259.8

e9/l

0.68

2010

18614

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

307

2.54

12.70

2.4

2.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

154

814

1.94

12.69

1.1

—

46.6

u/ml

—

(3010813) Leukocytes [#/volume] in Blood

2041

19239

2.29

12.54

28.9

14.4

6.9

6.7

e9/l

2.19

2004

18599

(40761539) Cells [Type] in Urine sediment by Light microscopy

7.47

12.53

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

201

2.91

12.53

5.0

5.4

2232.4

318.2

iu/ml

—

(3024731) MCV [Entitic volume]

2040

19228

2.28

12.50

28.7

14.4

90.3

89.9

2.52

2028

18932

(3021788) Differential panel - Synovial fluid

207

2.87

12.47

1.7

1.6

—

(3035941) MCH [Entitic mass]

2040

19230

2.27

12.46

28.7

14.3

30.0

0.60

2028

18936

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

4.27

12.45

2.6

3.8

61.3

113.1

nmol/l

2.26

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

440

2.26

12.43

1.3

1.1

—

(40768443) Skin Pathology biopsy report

118

571

2.11

12.43

1.3

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

2040

19232

2.27

12.42

28.7

14.4

4.5

e12/l

7.13

2006

18590

(3014765) Yersinia sp identified in Stool by Organism specific culture

442

2.25

12.30

1.3

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

2040

19240

2.26

12.27

29.1

14.5

133.3

135.1

g/l

7.55

2028

18950

(3038026) Centromere Ab [Units/volume] in Serum

3.94

12.24

1.1

1.2

—

42.9

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

8.78

11.85

1.3

1.2

0.1

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

127

644

2.01

11.80

2.1

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

127

646

2.00

11.70

2.2

2.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

375

2587

1.53

11.55

2.2

2.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

449

2.19

11.45

1.3

1.1

—

(3020891) Body temperature

398

2.26

11.42

5.4

4.4

—

(3008898) HLA-B27 [Presence]

125

638

2.00

11.41

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.78

11.27

1.4

2.2

—

(3024928) Oxygen saturation in Venous blood

255

2.57

11.12

3.0

5.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

881

7153

1.37

11.07

4.5

3.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

115

3.40

11.04

1.1

1.2

76.4

64.9

u/l

0.23

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

404

2863

1.49

10.89

2.3

2.2

—

(3011288) Drugs identified in Urine by Screen method

118

601

2.00

10.84

3.0

2.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

310

2.38

10.57

1.3

1.2

—

(3003338) MCHC [Mass/volume]

1385

15137

0.73

10.50

23.3

12.4

332.5

332.8

g/l

0.81

1379

15011

(3013293) Extractable nuclear Ab [Presence] in Serum

6.93

10.43

1.4

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

5.23

10.43

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.72

10.40

1.2

1.1

1.0

ratio

0.22

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

149

836

1.82

10.23

10.4

5.3

24.0

24.4

mmol/l

1.26

144

805

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.11

10.16

1.1

1.3

—

(3000012) Reticulocyte production index

4.26

10.13

1.2

1.3

—

(3004451) EKG impression Narrative

4.88

10.10

1.6

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

148

2.98

10.07

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

157

905

1.77

9.86

2.5

2.0

10.4

12.1

nmol/l

1.40

132

793

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

320

2.30

9.85

3.5

6.2

0.3

u/ml

0.02

162

(3014576) Chloride [Moles/volume] in Serum or Plasma

220

1391

1.63

9.82

10.7

7.5

104.3

104.9

mmol/l

0.92

215

1367

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

340

2.26

9.78

1.1

3.8

9.7

au/ml

—

(3008295) Osmolality of Serum or Plasma

140

3.01

9.77

1.4

1.6

283.1

284.8

mosm/kgh2o

0.20

109

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

3.56

9.75

2.4

2.1

575.6

493.5

e6/l

0.45

(3042517) Benzodiazepines panel - Urine

9.18

9.75

4.2

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

135

3.04

9.74

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.87

9.64

1.1

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

115

606

1.93

9.61

16.2

11.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

132

3.04

9.48

1.8

1.7

50.9

62.1

0.77

(21494755) Public health laboratory ask at order entry panel

110

1947

0.53

9.44

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

4.98

9.42

1.8

3.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

458

2.05

9.41

4.3

3.7

3.3

3.4

g/l

0.41

439

(3045683) HLA typing for celiac disease panel - Blood or Tissue

118

3.14

9.29

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

218

2.54

9.26

1.2

4.1

3.4

u/ml

0.12

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

410

3002

1.43

9.19

1.7

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

3.40

9.15

1.7

1.3

1.4

promille

0.05

(3011397) Hemoglobin [Presence] in Urine by Test strip

460

3447

1.41

9.04

4.0

2.9

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

105

3.24

9.00

1.4

1.5

10.0

11.0

umol/l

0.46

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

4.06

8.83

1.1

71.2

72.5

u/l

0.04

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

4.17

8.77

2.0

1.7

5.1

2.7

nmol/l

0.35

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

108

576

1.90

8.72

1.7

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

100

520

1.95

8.71

4.2

4.4

91.0

91.8

0.11

494

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

4.85

8.70

1.1

—

171.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

153

908

1.72

8.69

3.5

3.1

223.0

186.6

ng/l

0.47

133

827

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

3.99

8.64

1.1

11.7

15.5

u/l

0.47

(3021879) Hepatitis B virus core Ab [Presence] in Serum

196

1243

1.62

8.63

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

2.72

8.59

2.4

2.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.22

8.52

1.1

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

1761

16239

1.43

8.47

19.7

10.9

39.7

39.8

0.15

1208

12741

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.30

8.46

1.3

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.53

8.45

1.2

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.53

8.45

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

284

2.27

8.44

1.8

3.6

59.7

79.7

mg/l

0.29

244

(3022313) Gas panel - Capillary blood

148

878

1.72

8.42

9.8

5.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

120

3.00

8.42

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

443

2.01

8.41

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

285

2.26

8.37

1.8

3.6

25.6

42.0

mg/l

1.41

247

(1001926) Buprenorphine [Presence] in Urine by Screen method

124

702

1.79

8.30

2.1

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.84

8.23

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

400

2.04

8.17

2.3

2.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

203

2.47

8.05

1.8

3.5

—

(3036489) Thrombin time

102

549

1.88

8.03

3.6

2.8

22.1

21.8

0.18

487

(3045414) Leukocytes [Presence] in Urine

118

666

1.80

7.99

1.9

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

157

2.68

7.99

1.3

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

459

1.96

7.96

1.8

1.6

0.1

0.2

iu/ml

0.70

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

135

2.82

7.95

1.1

2.2

—

(3000060) B lymphocytes [#/volume] in Blood

4.10

7.86

2.9

2.0

435.6

375.9

e6/l

0.22

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

425

3213

1.39

7.81

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.24

7.81

1.3

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.68

7.76

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.80

7.74

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

472

1.93

7.68

1.9

1.7

1.3

1.5

g/l

1.57

401

(3016879) Cocaine [Presence] in Urine

143

863

1.69

7.66

2.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.33

7.61

1.2

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.15

7.60

2.1

2.0

14.6

14.7

umol/l

0.01

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

143

866

1.68

7.56

2.2

2.0

5.0

7.3

ug/l

2.26

122

766

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.30

7.56

2.4

1.8

190.0

208.0

umol/l

0.08

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

119

688

1.75

7.44

16.0

10.5

1.5

1.3

0.92

119

682

(3000093) Morphology [Interpretation] in Blood Narrative

113

2.92

7.39

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.87

7.27

5.8

5.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.33

7.25

1.4

1.5

5.8

5.0

u/l

0.11

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

15.62

7.18

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.28

7.14

1.7

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.27

7.10

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

149

929

1.63

7.05

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

7.64

7.03

1.1

1.0

—

(3016750) Collection duration of Urine

3.17

6.98

2.7

2.3

528.7

500.2

min

0.58

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

482

1.86

6.92

1.1

5.4

5.3

u/ml

0.01

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

309

2.08

6.91

1.6

1.4

0.2

0.5

nmol/l

2.85

253

(3027944) Amphetamines [Presence] in Urine

148

927

1.62

6.88

2.0

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

104

593

1.77

6.84

1.1

1.2

0.5

2.5

u/ml

3.25

318

(3027008) Opiates [Presence] in Urine

149

937

1.62

6.82

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

195

2.36

6.80

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.07

6.70

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

460

1.86

6.64

1.4

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

3.06

6.61

2.4

2.3

456.2

824.3

e6/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

288

2.09

6.59

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.20

6.57

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

148

940

1.60

6.51

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.68

6.49

1.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

115

687

1.69

6.44

3.3

4.1

125.5

129.6

g/l

1.05

107

671

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.99

6.37

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

183

2.35

6.32

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

294

2.05

6.26

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

166

2.41

6.22

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

166

1098

1.54

6.14

1.1

1.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

193

1320

1.49

6.09

28.5

23.6

1.4

1.3

inr

0.05

189

(3004809) Band form neutrophils/100 leukocytes in Blood

168

2.38

6.06

3.0

3.1

1.5

0.9

0.39

129

(3037756) Immunofixation for Serum or Plasma

193

2.28

6.05

1.3

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

213

2.21

5.99

1.2

6.2

7.1

u/ml

0.12

(3050129) First trimester maternal screen panel - Serum or Plasma

837

0.45

5.98

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

404

1.87

5.97

1.9

2.0

3.8

4.9

iu/l

0.62

153

(3011648) Oxygen content in Venous blood

122

2.62

5.93

2.6

7.9

11.1

0.03

122

(3006653) Thiamine [Moles/volume] in Blood

3.57

5.93

1.2

1.3

138.5

135.4

nmol/l

0.11

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.88

5.77

1.2

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

352

1.91

5.77

2.1

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

107

2.70

5.73

3.8

3.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

528

1.74

5.69

1.1

3.0

3.6

u/ml

0.07

169

(3020874) Milk IgE Ab [Units/volume] in Serum

206

2.19

5.62

1.4

0.8

5.0

u/ml

2.59

120

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

121

2.56

5.50

1.9

2.5

—

(40768795) Lymph node Pathology biopsy report

2.79

5.45

1.2

1.0

—

(3044927) Protein electrophoresis panel - Urine

2.79

5.45

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.79

5.44

1.2

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

563

4639

1.27

5.43

2.5

2.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

312

1.93

5.35

1.6

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

204

2.16

5.34

1.1

119.0

114.9

0.35

188

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

238

2.06

5.28

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

225

2.09

5.26

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

267

1.99

5.18

1.0

1.1

3.3

4.0

u/ml

0.14

127

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.97

5.18

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

105

652

1.62

5.12

2.3

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

317

1.90

5.12

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

115

2.51

5.01

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

158

2.28

5.00

2.8

4.0

40.7

132.2

u/ml

1.20

(3016330) Potassium [Moles/time] in 24 hour Urine

9.93

4.99

1.1

2.0

—

(4306422)

210

2.10

4.98

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.64

4.97

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

251

1875

1.37

4.88

1.7

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

141

2.34

4.87

4.2

2.6

—

(3004775) Volume in Urine collected for unspecified duration

105

2.56

4.86

2.7

2.4

681.9

577.4

0.45

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

199

2.11

4.85

3.9

3.3

215.8

152.9

u/ml

0.18

189

(3011897) Casein IgE Ab [Units/volume] in Serum

111

2.51

4.85

1.5

1.8

0.7

8.1

u/ml

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1690

15828

1.28

4.78

4.7

4.2

2.8

mmol/l

1.48

1567

14716

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.90

4.77

1.5

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

406

1.75

4.72

1.5

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

147

1005

1.48

4.69

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

2.52

4.69

1.7

1.5

—

(44813793)

157

2.23

4.64

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

108

2.49

4.60

1.1

1.2

80.0

156.4

titre

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

3.66

4.56

1.1

64.1

43.2

u/ml

0.44

(3028433) Virus identified in Specimen by Culture

3.66

4.56

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

127

2.36

4.54

1.3

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

140

2.28

4.50

1.2

4.0

25.2

u/ml

0.61

105

(1002224) Polysomnography panel

100

635

1.59

4.49

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

173

2.14

4.45

1.4

1.7

—

(40768446) Kidney Pathology biopsy report

3.25

4.38

2.4

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

166

1178

1.43

4.38

4.1

3.9

8.1

11.9

ug/l

0.48

135

935

(3015076) Soybean IgE Ab [Units/volume] in Serum

168

2.14

4.35

1.2

1.1

1.4

0.6

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1599

14930

1.24

4.34

3.9

3.4

1.3

1.2

mmol/l

4.26

1489

13843

(3051651) Icteric interference index of Serum or Plasma

2.67

4.32

4.3

2.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1664

15618

1.25

4.24

4.4

3.8

4.6

4.7

mmol/l

4.17

1556

14632

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.84

4.18

1.2

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1653

15513

1.24

4.15

4.4

3.8

1.4

1.5

mmol/l

6.79

1536

14443

(3008536) Aspergillus sp Ab [Presence] in Serum

6.87

4.13

1.2

1.8

—

(44790047)

146

2.19

4.11

1.8

1.6

—

(44790048)

146

2.19

4.11

1.8

1.6

—

(44806118)

146

2.19

4.11

1.8

1.6

—

(44790049)

146

2.19

4.11

1.8

1.6

—

(3045142) Bone marrow Pathology biopsy report

115

2.34

4.06

1.3

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

4.32

4.02

1.3

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.32

4.02

1.3

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.32

4.02

1.3

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.32

4.02

1.3

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

559

1.58

3.98

1.1

2.1

6.7

u/ml

5.10

364

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.84

3.98

2.1

5.7

9.8

8.6

mg/l

—

(4198724)

2.61

3.98

2.1

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

202

1.98

3.96

1.4

1.3

2.7

11.1

u/ml

0.71

109

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.74

3.93

1.9

1.6

3.4

u/field

0.49

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

196

1.99

3.91

1.5

1.6

—

(4268621)

143

2.16

3.89

2.2

2.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.40

3.83

1.1

1.5

108.5

105.9

nmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

226

1.90

3.81

1.0

1.2

—

(3037121) Protein [Mass/volume] in Urine

487

1.61

3.80

3.4

3.9

0.2

0.3

g/l

1.50

231

(3042733) HLA Ab [Presence] in Serum

3.31

3.69

4.7

3.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.58

3.62

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.58

3.62

2.2

1.1

—

(3020650) Glucose [Presence] in Urine

2.98

3.61

1.6

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

535

1.56

3.56

1.1

0.6

1.1

u/ml

0.69

317

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.52

3.55

1.1

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

239

1.84

3.54

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

512

1.57

3.54

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.25

3.47

1.7

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.82

3.46

1.6

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.52

3.42

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

369

1.65

3.40

1.1

8.8

7.5

u/ml

0.12

183

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.64

3.32

2.4

2.6

39.7

45.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

105

723

1.46

3.32

1.6

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

396

1.62

3.28

1.1

2.5

6.5

u/ml

1.71

183

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

129

1732

0.72

3.27

1.7

1.6

—

(40768441) Liver Pathology biopsy report

114

2.18

3.26

1.4

1.3

—

(3022725) Serotonin [Moles/volume] in Serum

8.50

3.24

1.0

1.4

994.2

2882.9

nmol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

109

2.19

3.17

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

733

0.59

3.16

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

671

0.57

3.16

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

670

0.57

3.14

1.3

1.4

—

(3002619) Bacteria identified in Specimen by Culture

3.54

3.14

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.84

3.12

1.3

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

668

0.57

3.11

1.3

1.4

—

(3022621) pH of Urine by Test strip

134

979

1.38

3.06

3.5

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

274

1.71

3.04

1.3

1.2

—

(3024471) HLA-A [Type]

3.05

3.03

1.0

—

(3044941) Cell count panel - Synovial fluid

194

1.85

3.01

1.6

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.42

2.99

1.2

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.42

2.98

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

4.25

2.96

1.7

1.1

—

(4010399)

137

1011

1.36

2.95

1.7

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1190

0.69

2.93

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

100

2.19

2.92

1.8

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

271

1.69

2.88

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.26

2.86

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.31

2.85

1.2

1.0

—

(3011436) Histone Ab [Units/volume] in Serum

4.06

2.85

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.61

2.84

1.3

1.1

—

(3022475) Manganese [Moles/volume] in Blood

6.61

2.84

1.2

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.61

2.84

14.2

7.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

5.34

2.84

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

5.34

2.84

1.1

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

288

1.66

2.81

2.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

672

0.60

2.80

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.41

2.76

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.75

2.76

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.62

2.73

1.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.20

2.72

1.2

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

194

1.80

2.71

3.2

2.9

0.8

0.9

nmol/l

0.48

153

(3045424) Erythrocytes [Presence] in Urine

239

1.71

2.68

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

4.18

2.65

1.4

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.57

2.64

1.8

2.3

—

(3047181) Lactate [Moles/volume] in Blood

348

1.58

2.63

6.5

5.3

1.6

1.2

mmol/l

0.73

299

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.10

2.59

1.0

—

(3017732) Neutrophils [#/volume] in Blood

141

1073

1.32

2.52

2.1

2.5

3.8

4.2

e9/l

1.35

108

885

(3019832) Treponema pallidum Ab [Presence] in Serum

276

2284

1.22

2.48

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.25

2.45

1.1

1635.2

1384.7

miu/ml

0.40

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

136

1729

0.76

2.44

3.8

4.0

31.2

32.4

0.71

105

1188

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

290

2418

1.22

2.42

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

130

1.91

2.38

3.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.96

2.38

4.2

4.8

—

(3028717) Thiamine [Mass/volume] in Blood

4.96

2.38

1.2

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.96

2.38

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

350

1.54

2.36

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

638

1.40

2.34

3.0

2.4

0.1

0.2

e6/l

1.79

613

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.61

2.33

1.1

1.0

—

(3024932) HLA-DR beta [Type]

2.73

2.32

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

160

1.80

2.32

1.0

-3.6

-2.1

mmol/l

—

(3006598) pH of Arterial cord blood

160

1.80

2.32

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

352

1.53

2.31

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

125

1.91

2.28

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

685

1.37

2.26

2.6

2.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.86

2.23

1.4

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

126

1595

0.77

2.21

9.5

5.3

—

(3006270) Folate [Moles/volume] in Blood

106

1.97

2.19

1.1

369.3

397.4

nmol/l

0.31

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.18

2.15

2.5

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.18

2.15

2.5

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

4.25

2.13

16.5

10.6

0.5

umol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.65

2.12

1.3

1.0

—

(3015183) Erythrocyte sedimentation rate

2.01

2.10

1.4

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.99

2.05

2.3

1.2

—

73.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.88

2.04

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.47

2.03

1.3

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.12

2.03

1.6

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.12

2.03

1.6

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.12

2.03

1.6

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

733

1.34

2.02

1.6

7.6

4.2

mg/l

0.64

480

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.09

1.97

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.61

1.97

2.1

1.5

10.8

9.2

ug/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.61

1.97

2.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

246

1.58

1.96

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.03

1.95

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.03

1.95

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

133

1.79

1.93

1.5

1.3

—

titre

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.50

1.92

1.0

1.1

—

43.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.72

1.91

1.0

1.1

1.2

1.8

umol/24h

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

297

1.51

1.87

1.8

2.7

5.4

7.0

umol/l

0.68

225

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

3.15

1.85

1.3

2.9

9.7

41.4

u/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

206

1709

1.21

1.85

2.1

1.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.91

1.84

2.5

2.1

1.1

1.8

u/field

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.14

1.83

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

170

1385

1.23

1.82

1.9

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

298

0.53

1.82

1.2

—

(3003694) ABO and Rh group [Type] in Blood

553

4972

1.14

1.80

1.7

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.96

1.80

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

2.19

1.79

1.0

1071.9

596.8

ng/l

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

108

1.84

1.76

1.2

1.4

8.7

16.6

u/ml

0.51

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

357

3120

1.16

1.75

5.0

4.8

3.2

2.3

ug/l

0.28

312

2786

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.15

1.73

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.48

1.71

2.2

2.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

192

1.61

1.71

1.1

8.4

6.4

iu/ml

—

(3019150) Specific gravity of Urine by Refractometry

373

3277

1.15

1.71

4.7

3.2

1.0

kg/l

0.39

506

(3005033) Fetal Nuchal fold Thickness US

546

0.66

1.70

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

321

1.46

1.68

4.7

2.2

1.0

0.7

nmol/l

1.85

271

(3025577) Chromium [Mass/volume] in Blood

2.11

1.67

2.5

2.1

2.8

2.6

ug/l

0.05

(4034850)

472

0.64

1.66

7.1

7.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

565

0.68

1.64

1.3

1.4

—

(3017509) Phencyclidine [Presence] in Urine

3.13

1.64

4.3

1.2

—

(4094501)

349

1.43

1.61

1.1

—

(3018133) Calcium [Moles/volume] in Urine

2.01

1.60

2.4

4.3

3.2

2.4

mmol/l

0.67

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.54

1.60

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

325

1.44

1.59

1.1

0.0

0.4

u/ml

3.15

119

(40768806) Pleura Pathology biopsy report

105

1.80

1.58

1.8

1.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.97

1.56

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.67

1.56

1.3

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

2.05

1.55

2.5

2.1

4.4

3.3

ug/l

0.38

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

206

1.54

1.53

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.18

1.53

1.5

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

183

1.58

1.51

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.30

1.50

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.57

1.49

1.0

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.14

1.47

1.5

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.85

1.46

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

108

1.75

1.45

1.8

1.4

—

(40761535) Cells panel - Urine sediment

128

1040

1.23

1.45

4.0

2.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

146

1.63

1.45

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.93

1.44

1.8

3.9

122.7

123.0

umol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

548

0.70

1.43

1.3

1.4

—

(21494434) Karyotype in Bone marrow

109

1.73

1.42

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.29

1.41

2.3

5.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.16

1.36

3.7

3.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.18

1.35

2.3

5.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

304

1.41

1.33

3.6

2.5

157.2

80.8

ug/min

0.47

189

(3024522) Salmonella sp identified in Specimen by Organism specific culture

143

1.60

1.30

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

120

1.65

1.29

3.3

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.48

1.28

1.2

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

495

1.31

1.28

1.8

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

282

1.41

1.27

1.3

1.1

111.2

1701.4

iu/ml

0.52

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

341

1.37

1.27

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.75

1.27

2.0

1.9

—

(3017704) Immunofixation for Urine

2.07

1.24

1.2

1.7

—

(4015189)

2.38

1.22

1.8

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

421

1.32

1.22

2.9

3.2

395.3

3209.3

u/ml

0.62

360

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.84

1.20

1.4

1.9

—

(3006462) Nitrate [Presence] in Urine

1.84

1.20

2.5

2.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.14

1.20

1.6

1.4

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.75

1.19

1.0

159.8

164.4

g/l

0.68

(3025468) Yersinia sp identified in Specimen by Organism specific culture

147

1.55

1.18

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

147

1.55

1.18

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.29

1.17

1.0

1.3

—

19.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

148

1.54

1.15

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.69

1.13

1.2

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

389

3523

1.11

1.12

2.7

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.67

1.10

2.5

2.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

175

1.48

1.08

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.36

1.07

1.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.17

1.07

1.6

2.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

143

1.53

1.07

1.4

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

1.94

1.03

1.3

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.78

1.01

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

111

1288

0.84

0.98

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

509

1.25

0.96

4.1

3.4

25.5

24.9

mmol/l

0.72

489

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

171

0.58

0.94

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.94

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.20

0.93

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.20

0.93

1.0

1.3

—

(3034426) Prothrombin time (PT)

1.87

0.92

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

276

1.33

0.90

1.5

1.3

29.2

22.0

u/l

0.50

226

(4211845)

1.65

0.88

2.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

110

1.53

0.87

2.1

1.3

39277.8

78187.6

e6/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

287

1.32

0.86

1.7

5295.8

12414.3

e6/l

1.76

214

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

237

0.67

0.85

4.0

3.5

17.9

34.8

u/ml

1.72

230

(4024509)

111

1.52

0.84

1.8

1.4

—

(40768793) Breast Pathology biopsy report

385

1.26

0.83

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

440

1.24

0.81

1.8

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.69

0.79

2.4

2.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

676

0.81

0.79

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.59

0.78

1.7

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.80

0.78

1.2

2.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

122

1.46

0.76

2.1

1.3

1572.4

2264.8

e6/l

0.51

(3036782) Glucose [Moles/volume] in Pleural fluid

1.52

0.75

1.3

6.2

6.7

mmol/l

0.36

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.57

0.75

5.6

6.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

610

1.19

0.73

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.53

0.72

1.2

2.2

—

(3045788) Cell count panel - Pleural fluid

100

1.49

0.69

2.2

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.69

1.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.69

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.69

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.69

1.6

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.65

0.67

3.1

2.0

—

(3047189) Immunofixation for 24 hour Urine

1.58

0.64

1.6

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.71

0.63

2.2

1.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.60

0.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.60

0.0

5.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.59

0.0

4.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

225

1.28

0.59

1.4

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

325

0.79

0.54

4.1

3.2

19.8

25.9

mg/l

0.36

206

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.47

0.54

1.2

1.3

7.5

6.3

u/ml

—

(3024263) Appearance of Synovial fluid

1.51

0.54

1.0

1.8

—

(3022670) pH of Venous cord blood

1.56

0.53

1.0

—

(4146454)

135

0.66

0.51

3.0

2.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.48

0.51

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.54

0.48

1.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

142

0.70

0.48

1.6

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.48

0.47

1.0

1.1

—

(3035880) pH of Pleural fluid

1.47

0.47

1.7

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

677

0.87

0.45

1.7

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

120

1.32

0.43

2.3

2.7

151.7

59.5

u/ml

0.35

120

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

199

1847

1.07

0.40

3.3

3.0

0.7

0.8

ug/l

0.11

126

1175

(44806420)

1.41

0.39

2.0

2.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

107

1.30

0.35

2.5

55.6

54.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.38

0.34

2.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

185

0.80

0.32

1.5

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

106

0.75

0.29

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

552

1.10

0.26

1.8

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.30

0.23

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.30

0.23

1.2

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

134

0.81

0.22

2.3

2.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.21

0.21

1.8

4.6

1.2

mmol/l

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.22

0.21

1.4

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

262

2509

1.04

0.21

4.2

21.6

21.5

0.06

109

1188

(40768800) Prostate Pathology biopsy report

190

1.15

0.20

1.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.4

—

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

111

0.80

0.20

1.9

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

678

0.93

0.19

1.3

208.6

226.2

miu/ml

0.20

342

(1617658) Protocol used for examination of sentinel lymph nodes

140

0.85

0.17

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

109

1.18

0.17

1.2

1.5

236258.2

75970.5

e6/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.16

1.5

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

315

0.91

0.16

2.2

3.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

160

0.86

0.16

1.3

1.4

6.8

11.2

mmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.16

0.15

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

115

0.86

0.12

1.1

1.5

—

(3019225) pH of Specimen

127

1222

1.03

0.10

4.0

3.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

109

1047

1.03

0.09

1.8

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

124

1.12

0.09

1.6

1.3

1.1

1.0

g/l

0.46

124

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

492

1.05

0.09

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.81

0.08

1.0

1.2

—

(4281824)

155

1.09

0.07

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.11

0.06

1.7

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

235

0.97

0.01

1.2

1.4

5.5

7.1

mmol/l

3.67

168

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.00

0.00

3.3

2.5

—

(3025130) Human papilloma virus identified in Specimen

274

1.01

0.00

1.7

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

386

1.00

0.00

1.4

1.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.0

—

34.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.94

0.00

1.9

1.7

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.0

—

51.2

—

(3025315) Body weight

0.00

0.0

4.8

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.84

0.00

4.0

3.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

9.8

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.0

—

2.2

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

5.5

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_OTHER_GENERAL_SYMPTOMS_SIGNS – Other general symptoms and signs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other general symptoms and signs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other general symptoms and signs (R18_OTHER_GENERAL_SYMPTOMS_SIGNS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints